不妊症検査及び治療の世界市場予測2019-2027

Inkwood Researchが発行した調査報告書(INKW906045)
◆英語タイトル:GLOBAL INFERTILITY TESTING AND TREATMENT MARKET FORECAST 2019-2027
◆商品コード:INKW906045
◆発行会社(リサーチ会社):Inkwood Research
◆発行日:2019年4月1日
◆ページ数:148
◆レポート形式:英語 / PDF
◆納品方法:Eメール
◆調査対象地域:グローバル
◆産業分野:医療
◆販売価格オプション(消費税別)
Single UserUSD2,500 ⇒換算¥275,000見積依頼/購入/質問フォーム
Multi LicenseUSD3,000 ⇒換算¥330,000見積依頼/購入/質問フォーム
Enterprisewide PriceUSD4,500 ⇒換算¥495,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はInkwood Research社の日本における正規代理店です。同社発行の市場リサーチレポート及びリサーチサービスに関するお問い合わせは弊社までお願い致します。Inkwood Research社の概要及び新刊レポートはこちらでご確認いただけます。

Inkwoodリサーチが調査・発行した本調査レポートでは、不妊症検査及び治療のグローバル市場について調べ、不妊症検査及び治療の市場動向、市場規模、セグメント別市場規模、主要企業情報などをまとめました。
【レポートの概要】

KEY FINDINGSInfertility is defined as the inability of a couple to conceive naturally after at least one year of regular unprotected sexual intercourse. It remains a major clinical and social problem, affecting perhaps every one couple out of six. Evaluation usually begins post 12 months; however, it may be indicated earlier depending on the case.
Global infertility testing and treatment market are estimated to grow with approx. 6.39% CAGR during the year 2019-2027. The base year considered for the study is 2018 and the forecast period is 2019-2027.
The rise in infertility and treatment awareness and the introduction of new testing devices is fueling growth in global infertility testing and treatment market.
MARKET INSIGHTS
The global infertility testing and treatment market are primarily driven because of the advances in healthcare where there has been the availability of fine-tuned fertility treatment. Physiological causes that may cause infertility are a tubal blockage, congenital malformation, abnormal ovulation, low quality and quantity of sperm and ejaculatory dysfunctions. Additionally, infection, higher age, pollution, and other environmental hazards may lead to infertility.
Moreover, increasing success rates of IVF is encouraging the patients to undergo the treatment. Despite various motivators, the market is experiencing a slower growth rate due to the high cost of treatment.
REGIONAL INSIGHTS
Geographically, the global infertility testing and treatment market have been segmented on the basis of four major regions, which are North America, Europe, Asia Pacific and the remaining countries forming the Rest of World regional segment.
The European market is expected to capture the highest market share by the end of the estimated period. The region has the presence of numerous IVF clinics that provide treatments at reasonable costs. The APAC market is also forecasted to exhibit a significant growth over the forecast period, driven by a low birth rate and favorable government initiatives in some major Asian countries such as Japan, South Korea, Singapore, and Taiwan.
COMPETITIVE INSIGHTS
The eminent companies operating in the market that are profiled in the report are Ferring Pharmaceuticals, Progyny, Thermo Fisher Scientific Inc., Genea, Ovascience, The Cooper Companies, Inc., Andrology Solutions, Merck, Esco Micro PTE. Ltd., Halotech DNA, Irvine Scientific, Vitrolife AB, Origio, Quest Diagnostic, and Endo Pharmaceuticals. These companies depend on many organic and inorganic strategies for their expansion.

【レポートの目次】

1. RESEARCH SCOPE
1.1. STUDY GOALS
1.2. SCOPE OF THE MARKET STUDY
1.3. WHO WILL FIND THIS REPORT USEFUL?
1.4. STUDY AND FORECASTING YEARS
2. RESEARCH METHODOLOGY
2.1. SOURCES OF DATA
2.1.1. SECONDARY DATA
2.1.2. PRIMARY DATA
2.2. TOP-DOWN APPROACH
2.3. BOTTOM-UP APPROACH
2.4. DATA TRIANGULATION
3. EXECUTIVE SUMMARY
3.1. MARKET SUMMARY
3.2. KEY FINDINGS
3.2.1. EUROPE IS THE LARGEST MARKET
3.2.2. ASIA PACIFIC IS THE FASTEST GROWING REGION IN THE INFERTILITY MARKET
3.2.3. IVF DOMINATES THE FEMALE TREATMENT MARKET
3.2.4. OXIDATIVE STRESS ANALYSIS IS THE FASTEST GROWING MALE INFERTILITY TESTING MARKET
4. MARKET OVERVIEW
4.1. MARKET DEFINITION
4.2. MARKET DRIVERS AND IMPACT
4.2.1. RISE IN INFERTILITY AND TREATMENT AWARENESS
4.2.2. MEDICAL TOURISM FOR FERTILITY TREATMENTS
4.2.3. SURROGACY LAWS ARE GETTING MORE DEFINED
4.2.4. HEALTHCARE ADVANCES HAVE FINETUNED FERTILITY TREATMENT
4.2.5. INCREASING EFFECTIVENESS OF TREATMENTS
4.2.6. HEALTHIER DONOR EGGS
4.2.7. INTRODUCTION OF NEW TESTING DEVICES
4.3. MARKET RESTRAINTS AND IMPACT
4.3.1. TREATMENT PROCEDURE OUT OF REACH TO MANY DUE TO COSTS INVOLVED
4.3.2. COUNTRY-WISE REGULATORY ISSUES
4.4. MARKET OPPORTUNITIES
4.4.1. REDUCING THE COST OF TREATMENT TO MAKE IT MORE ACCESSIBLE
4.4.2. IVF ATTRACTING INVESTMENTS FROM PRIVATE EQUITY INVESTORS
4.4.3. DIY TESTING INCREASING ACCESS AND REDUCING COST
4.5. MARKET CHALLENGES
4.5.1. INFERTILITY CONSIDERED A SOCIAL TABOO AMONGST MEN
4.5.2. PERILS OF MULTIPLE PREGNANCIES
4.5.3. TRADITIONAL TREATMENTS USED WIDELY AS AN ALTERNATIVE FOR INFERTILITY TREATMENTS
4.5.3.1. DIET AND SUPPLEMENTS
4.5.3.2. ACUPUNCTURE
4.5.3.3. THERAPY
4.5.3.4. QIGONG
5. INFERTILITY CAUSES
5.1. CAUSES OF MALE INFERTILITY
5.1.1. ABNORMALITY IN THE SPERM
5.1.2. ENVIRONMENTAL FACTORS
5.1.3. POOR HEALTH AND LIFESTYLE
5.2. CAUSES OF FEMALE INFERTILITY
5.2.1. OVULATION DISORDERS
5.2.2. DAMAGE TO FALLOPIAN TUBES
5.3. MORAL QUESTIONS
6. MALE INFERTILITY TESTING AND TREATMENT MARKET 2019-2027 ($ MILLION)
6.1. MARKET BY MALE INFERTILITY TESTING
6.1.1. DNA FRAGMENTATION
6.1.2. OXIDATIVE STRESS ANALYSIS
6.1.3. SPERM PENETRATION ASSAY
6.1.4. COMPUTER ASSISTED SEMEN ANALYSIS (CASA)
6.1.5. SPERM AGGLUTINATION
6.1.6. MICROSCOPIC EXAMINATION
6.1.7. OTHERS
6.2. MARKET BY MALE INFERTILITY TREATMENT
6.2.1. VASOVASOSTOMY AND VASOEPIDIDYMOSTOMY (VASECTOMY REVERSAL)
6.2.2. SPERM RETRIEVAL TREATMENT
6.2.3. MICROSURGICAL SPERM ASPIRATION (MESA)
6.2.4. TESTICULAR SPERM EXTRACTION (TESE)
6.2.5. VARICOCELE REPAIRS
6.2.6. ASSISTED REPRODUCTIVE TECHNIQUES (ART)
6.2.7. INTRAUTERINE INSEMINATION (IUI)
6.2.8. IN VITRO FERTILIZATION (IVF)
6.2.9. INTRACYTOPLASMIC SPERM INJECTION (ICSI)
7. FEMALE INFERTILITY TESTING AND TREATMENT MARKET 2019-2027 ($ MILLION)
7.1. MARKET BY FEMALE INFERTILITY TESTING
7.1.1. OVULATION TESTING
7.1.2. HYSTEROSALPINGOGRAPHY
7.1.3. LAPAROSCOPY
7.1.4. TRANSVAGINAL ULTRASOUND
7.1.5. OVARIAN RESERVE TESTING
7.1.6. HORMONAL LEVEL TESTING
7.1.7. OTHERS (GENETIC TESTING)
7.2. MARKET BY FEMALE INFERTILITY TREATMENT
7.2.1. IN VITRO FERTILIZATION
7.2.2. INTRAUTERINE INSEMINATION (IUI)
7.2.3. DRUG AND HORMONE THERAPIES
8. GLOBAL INFERTILITY TESTING AND TREATMENT MARKET BY END-USERS 2019-2027 ($ MILLION)
8.1. FERTILITY AND SURGICAL CENTERS
8.2. HOSPITALS AND RESEARCH LABORATORIES
8.3. CRYOBANKS
9. KEY ANALYTICS
9.1. PORTER’S 5 FORCE MODEL
9.1.1. THREAT OF NEW ENTRANTS
9.1.2. THREAT OF SUBSTITUTE PRODUCTS
9.1.3. BARGAINING POWER OF BUYERS
9.1.4. BARGAINING POWER OF SUPPLIERS
9.1.5. INTENSITY OF COMPETITIVE RIVALRY
9.2. VALUE CHAIN ANALYSIS
9.2.1. RAW MATERIAL PROCUREMENT
9.2.2. MANUFACTURING
9.2.3. SUPPLY LOGISTICS
9.2.4. DISTRIBUTION CHANNELS
9.2.5. END-USERS
9.3. KEY BUYING CRITERIA
9.3.1. TREATMENT OPTIONS
9.3.2. QUALITY OF MEDICAL PROCEDURES
9.3.3. PRICE OF TREATMENTS
9.3.4. SHIFT TOWARDS MEDICAL TOURISM
9.3.5. REIMBURSEMENT
9.4. REGULATORY FRAMEWORK
9.5. VENDOR LANDSCAPE
9.6. OPPORTUNITY MATRIX
10. GLOBAL INFERTILITY TESTING AND TREATMENT MARKET REGIONAL ANALYSIS 2019-2027 ($ MILLION)
10.1. NORTH AMERICA
10.1.1. US
10.1.2. CANADA
10.2. ASIA PACIFIC
10.2.1. CHINA
10.2.2. INDIA
10.2.3. JAPAN
10.2.4. SOUTH KOREA
10.2.5. REST OF ASIA-PACIFIC
10.3. EUROPE
10.3.1. UK
10.3.2. GERMANY
10.3.3. FRANCE
10.3.4. NORDICS
10.3.5. RUSSIA
10.4. REST OF WORLD
11. COMPANY PROFILES
11.1. ANDROLOGY SOLUTIONS
11.2. ENDO PHARMACEUTICALS
11.3. PROGYNY
11.4. FERRING PHARMACEUTICALS
11.5. GENEA
11.6. HALOTECH DNA
11.7. IRVINE SCIENTIFIC
11.8. MERCK
11.9. ORIGIO
11.10. OVASCIENCE
11.11. VITROLIFE AB
11.12. THERMO FISHER SCIENTIFIC INC.
11.13. THE COOPER COMPANIES, INC.
11.14. QUEST DIAGNOSTIC
11.15. ESCO MICRO PTE. LTD.

LIST OF TABLES
TABLE 1 GLOBAL INFERTILITY TESTING AND TREATMENT MARKET BY GENDER 2019-2027 ($ MILLION)
TABLE 2 AVERAGE COST COMPARISON OF INFERTILITY TREATMENTS
TABLE 3 GLOBAL MALE INFERTILITY TESTING AND TREATMENT MARKET 2019-2027 ($ MILLION)
TABLE 4 GLOBAL MALE INFERTILITY TESTING MARKET 2019-2027($ MILLION)
TABLE 5 PROS AND CONS OF DNA SHARING METHODS
TABLE 6 GLOBAL DNA FRAGMENTATION MARKET BY REGION, 2019-2027 ($ MILLION)
TABLE 7 GLOBAL OXIDATIVE STRESS ANALYSIS MARKET BY REGION, 2019-2027 ($ MILLION)
TABLE 8 GLOBAL SPERM PENETRATION ASSAY MARKET BY REGION 2019-2027 ($ MILLION)
TABLE 9 GLOBAL CASA MARKET BY REGION 2019-2027 ($ MILLION)
TABLE 10 GLOBAL SPERM AGGLUTINATION MARKET BY REGION2019-2027 ($ MILLION)
TABLE 11 GLOBAL MICROSCOPIC EXAMINATION MARKET BY REGION 2019-2027 ($ MILLION)
TABLE 12 GLOBAL FEMALE INFERTILITY TESTING AND TREATMENT MARKET 2019-2027 ($ MILLION)
TABLE 13 GLOBAL FEMALE INFERTILITY TESTING MARKET 2019-2027 ($ MILLION)
TABLE 14 COST OF OVULATION TESTING KITS IN THE US
TABLE 15 GLOBAL OVULATION TESTING MARKET BY REGION 2019-2027 ($ MILLION)
TABLE 16 GLOBAL HYSTEROSALPINGOGRAPHY MARKET BY REGION 2019-2027 ($ MILLION)
TABLE 17 GLOBAL LAPAROSCOPY MARKET BY REGION 2019-2027 ($ MILLION)
TABLE 18 GLOBAL TRANSVAGINAL ULTRASOUND MARKET BY REGION 2019-2027 ($ MILLION)
TABLE 19 GLOBAL OVARIAN RESERVE TESTING MARKET BY REGION 2019-2027 ($ MILLION)
TABLE 20 GLOBAL HORMONAL LEVEL TESTING MARKET BY REGION 2019-2027 ($ MILLION)
TABLE 21 COST OF HORMONAL TEST IN THE US
TABLE 22 GLOBAL FEMALE INFERTILITY TREATMENT MARKET 2019-2027 ($ MILLION)
TABLE 23 AVERAGE COST OF SOME INFERTILITY TREATMENTS
TABLE 24 GLOBAL IVF TREATMENT MARKET BY REGION 2019-2027 ($ MILLION)
TABLE 25 GLOBAL IUI TREATMENT MARKET BY REGION 2019-2027 ($ MILLION)
TABLE 26 GLOBAL DRUG AND HORMONE THERAPIES MARKET BY REGION 2019-2027 ($ MILLION)
TABLE 27 SOME COMMON DRUG THERAPIES
TABLE 28 GLOBAL INFERTILITY TESTING AND TREATMENT MARKET BY END-USERS 2019-2027 ($ MILLION)
TABLE 29 GLOBAL FERTILITY AND SURGICAL CENTERS MARKET BY REGION 2019-2027 ($ MILLION)
TABLE 30 GLOBAL HOSPITALS AND RESEARCH LABORATORIES MARKET BY REGION 2019-2027 ($ MILLION)
TABLE 31 GLOBAL CRYOBANKS MARKET BY REGION 2019-2027 ($ MILLION)
TABLE 32 GLOBAL INFERTILITY TESTING AND TREATMENT MARKET BY GEOGRAPHY 2019-2027 ($ MILLION)
TABLE 33 NORTH AMERICA INFERTILITY TESTING AND TREATMENT MARKET BY COUNTRY 2019-2027 ($ MILLION)
TABLE 34 SUCCESS OF ASSISTED REPRODUCTIVE TECHNOLOGY (ART) USING DONOR EGGS IN THE U.S. IN 2013
TABLE 35 COSTS FOR INFERTILITY TREATMENTS IN THE U.S. 2015
TABLE 36 COST OF IVF & ICSI TREATMENT, CANADA 2014
TABLE 37 ASIA-PACIFIC INFERTILITY TESTING AND TREATMENT MARKET BY COUNTRY 2019-2027 ($ MILLION)
TABLE 38 EUROPE INFERTILITY TESTING AND TREATMENT MARKET BY COUNTRY 2019-2027 ($ MILLION)
TABLE 39 COST OF IVF IN RUSSIA

LIST OF FIGURES
FIGURE 1 GLOBAL INFERTILITY TESTING AND TREATMENT MARKET 2019-2027 ($ MILLION)
FIGURE 2 MAJOR FERTILITY TREATMENT DESTINATION RANKING
FIGURE 3 CLINICAL ALGORITHM FOR THE EVALUATION OF INFERTILE WOMAN
FIGURE 4 RATE OF MULTIPLE DELIVERIES
FIGURE 5 CAUSES OF INFERTILITY
FIGURE 6 CAUSES OF INFERTILITY BASED ON GENDER
FIGURE 7 CAUSES OF SPERM DNA FRAGMENTATION
FIGURE 8 WORLDWIDE FALLING FERTILITY RATE (TOTAL BIRTHS PER WOMAN)
FIGURE 9 NUMBER OF IVF CYCLES PERFORMED IN THE US
FIGURE 10 US INFERTILITY TESTING AND TREATMENT MARKET 2019-2027 ($ MILLION)
FIGURE 11 CANADA INFERTILITY TESTING AND TREATMENT MARKET 2019-2027 ($ MILLION)
FIGURE 12 GROWTH IN IVF CLINICS IN ASIA
FIGURE 13 CHINA INFERTILITY TESTING AND TREATMENT MARKET 2019-2027 ($ MILLION)
FIGURE 14 INDIA INFERTILITY TESTING AND TREATMENT MARKET 2019-2027 ($ MILLION)
FIGURE 15 JAPAN INFERTILITY TESTING AND TREATMENT MARKET 2019-2027(MILLION)
FIGURE 16 SOUTH KOREA INFERTILITY TESTING AND TREATMENT MARKET 2019-2027 (MILLION)
FIGURE 17 MEDICAL TOURISM IN SOUTH KOREA ($ MILLION)
FIGURE 18 REST OF ASIA-PACIFIC INFERTILITY TESTING AND TREATMENT MARKET 2019-2027 ($ MILLION)
FIGURE 19 UK INFERTILITY TESTING AND TREATMENT MARKET 2019-2027 ($ MILLION)
FIGURE 20 FERTILITY TREATMENT IN 2014
FIGURE 21 GERMANY INFERTILITY TESTING AND TREATMENT MARKET 2019-2027 ($ MILLION)
FIGURE 22 FRANCE INFERTILITY TESTING AND TREATMENT MARKET 2019-2027 ($ MILLION)
FIGURE 23 NORDICS INFERTILITY TESTING AND TREATMENT MARKET 2019-2027 ($ MILLION)
FIGURE 24 RUSSIA INFERTILITY TESTING AND TREATMENT MARKET 2019-2027 ($ MILLION)
FIGURE 25 REST OF THE WORLD INFERTILITY TESTING AND TREATMENT MARKET 2019-2027 ($ MILLION)

LIST OF TABLES
TABLE 1 GLOBAL INFERTILITY TESTING AND TREATMENT MARKET BY GENDER 2019-2027 ($ MILLION)
TABLE 2 AVERAGE COST COMPARISON OF INFERTILITY TREATMENTS
TABLE 3 GLOBAL MALE INFERTILITY TESTING AND TREATMENT MARKET 2019-2027 ($ MILLION)
TABLE 4 GLOBAL MALE INFERTILITY TESTING MARKET 2019-2027($ MILLION)
TABLE 5 PROS AND CONS OF DNA SHARING METHODS
TABLE 6 GLOBAL DNA FRAGMENTATION MARKET BY REGION, 2019-2027 ($ MILLION)
TABLE 7 GLOBAL OXIDATIVE STRESS ANALYSIS MARKET BY REGION, 2019-2027 ($ MILLION)
TABLE 8 GLOBAL SPERM PENETRATION ASSAY MARKET BY REGION 2019-2027 ($ MILLION)
TABLE 9 GLOBAL CASA MARKET BY REGION 2019-2027 ($ MILLION)
TABLE 10 GLOBAL SPERM AGGLUTINATION MARKET BY REGION2019-2027 ($ MILLION)
TABLE 11 GLOBAL MICROSCOPIC EXAMINATION MARKET BY REGION 2019-2027 ($ MILLION)
TABLE 12 GLOBAL FEMALE INFERTILITY TESTING AND TREATMENT MARKET 2019-2027 ($ MILLION)
TABLE 13 GLOBAL FEMALE INFERTILITY TESTING MARKET 2019-2027 ($ MILLION)
TABLE 14 COST OF OVULATION TESTING KITS IN THE US
TABLE 15 GLOBAL OVULATION TESTING MARKET BY REGION 2019-2027 ($ MILLION)
TABLE 16 GLOBAL HYSTEROSALPINGOGRAPHY MARKET BY REGION 2019-2027 ($ MILLION)
TABLE 17 GLOBAL LAPAROSCOPY MARKET BY REGION 2019-2027 ($ MILLION)
TABLE 18 GLOBAL TRANSVAGINAL ULTRASOUND MARKET BY REGION 2019-2027 ($ MILLION)
TABLE 19 GLOBAL OVARIAN RESERVE TESTING MARKET BY REGION 2019-2027 ($ MILLION)
TABLE 20 GLOBAL HORMONAL LEVEL TESTING MARKET BY REGION 2019-2027 ($ MILLION)
TABLE 21 COST OF HORMONAL TEST IN THE US
TABLE 22 GLOBAL FEMALE INFERTILITY TREATMENT MARKET 2019-2027 ($ MILLION)
TABLE 23 AVERAGE COST OF SOME INFERTILITY TREATMENTS
TABLE 24 GLOBAL IVF TREATMENT MARKET BY REGION 2019-2027 ($ MILLION)
TABLE 25 GLOBAL IUI TREATMENT MARKET BY REGION 2019-2027 ($ MILLION)
TABLE 26 GLOBAL DRUG AND HORMONE THERAPIES MARKET BY REGION 2019-2027 ($ MILLION)
TABLE 27 SOME COMMON DRUG THERAPIES
TABLE 28 GLOBAL INFERTILITY TESTING AND TREATMENT MARKET BY END-USERS 2019-2027 ($ MILLION)
TABLE 29 GLOBAL FERTILITY AND SURGICAL CENTERS MARKET BY REGION 2019-2027 ($ MILLION)
TABLE 30 GLOBAL HOSPITALS AND RESEARCH LABORATORIES MARKET BY REGION 2019-2027 ($ MILLION)
TABLE 31 GLOBAL CRYOBANKS MARKET BY REGION 2019-2027 ($ MILLION)
TABLE 32 GLOBAL INFERTILITY TESTING AND TREATMENT MARKET BY GEOGRAPHY 2019-2027 ($ MILLION)
TABLE 33 NORTH AMERICA INFERTILITY TESTING AND TREATMENT MARKET BY COUNTRY 2019-2027 ($ MILLION)
TABLE 34 SUCCESS OF ASSISTED REPRODUCTIVE TECHNOLOGY (ART) USING DONOR EGGS IN THE U.S. IN 2013
TABLE 35 COSTS FOR INFERTILITY TREATMENTS IN THE U.S. 2015
TABLE 36 COST OF IVF & ICSI TREATMENT, CANADA 2014
TABLE 37 ASIA-PACIFIC INFERTILITY TESTING AND TREATMENT MARKET BY COUNTRY 2019-2027 ($ MILLION)
TABLE 38 EUROPE INFERTILITY TESTING AND TREATMENT MARKET BY COUNTRY 2019-2027 ($ MILLION)
TABLE 39 COST OF IVF IN RUSSIA


LIST OF FIGURES
FIGURE 1 GLOBAL INFERTILITY TESTING AND TREATMENT MARKET 2019-2027 ($ MILLION)
FIGURE 2 MAJOR FERTILITY TREATMENT DESTINATION RANKING
FIGURE 3 CLINICAL ALGORITHM FOR THE EVALUATION OF INFERTILE WOMAN
FIGURE 4 RATE OF MULTIPLE DELIVERIES
FIGURE 5 CAUSES OF INFERTILITY
FIGURE 6 CAUSES OF INFERTILITY BASED ON GENDER
FIGURE 7 CAUSES OF SPERM DNA FRAGMENTATION
FIGURE 8 WORLDWIDE FALLING FERTILITY RATE (TOTAL BIRTHS PER WOMAN)
FIGURE 9 NUMBER OF IVF CYCLES PERFORMED IN THE US
FIGURE 10 US INFERTILITY TESTING AND TREATMENT MARKET 2019-2027 ($ MILLION)
FIGURE 11 CANADA INFERTILITY TESTING AND TREATMENT MARKET 2019-2027 ($ MILLION)
FIGURE 12 GROWTH IN IVF CLINICS IN ASIA
FIGURE 13 CHINA INFERTILITY TESTING AND TREATMENT MARKET 2019-2027 ($ MILLION)
FIGURE 14 INDIA INFERTILITY TESTING AND TREATMENT MARKET 2019-2027 ($ MILLION)
FIGURE 15 JAPAN INFERTILITY TESTING AND TREATMENT MARKET 2019-2027(MILLION)
FIGURE 16 SOUTH KOREA INFERTILITY TESTING AND TREATMENT MARKET 2019-2027 (MILLION)
FIGURE 17 MEDICAL TOURISM IN SOUTH KOREA ($ MILLION)
FIGURE 18 REST OF ASIA-PACIFIC INFERTILITY TESTING AND TREATMENT MARKET 2019-2027 ($ MILLION)
FIGURE 19 UK INFERTILITY TESTING AND TREATMENT MARKET 2019-2027 ($ MILLION)
FIGURE 20 FERTILITY TREATMENT IN 2014
FIGURE 21 GERMANY INFERTILITY TESTING AND TREATMENT MARKET 2019-2027 ($ MILLION)
FIGURE 22 FRANCE INFERTILITY TESTING AND TREATMENT MARKET 2019-2027 ($ MILLION)
FIGURE 23 NORDICS INFERTILITY TESTING AND TREATMENT MARKET 2019-2027 ($ MILLION)
FIGURE 24 RUSSIA INFERTILITY TESTING AND TREATMENT MARKET 2019-2027 ($ MILLION)
FIGURE 25 REST OF THE WORLD INFERTILITY TESTING AND TREATMENT MARKET 2019-2027 ($ MILLION)


【掲載企業】

1. ANDROLOGY SOLUTIONS
2. ENDO PHARMACEUTICALS
3. PROGYNY
4. FERRING PHARMACEUTICALS
5. GENEA
6. HALOTECH DNA
7. IRVINE SCIENTIFIC
8. MERCK
9. ORIGIO
10. OVASCIENCE
11. VITROLIFE AB
12. THERMO FISHER SCIENTIFIC INC.
13. THE COOPER COMPANIES, INC.
14. QUEST DIAGNOSTIC
15. ESCO MICRO PTE. LTD.



【免責事項】
http://www.globalresearch.jp/disclaimer

★リサーチレポート[ 不妊症検査及び治療の世界市場予測2019-2027(GLOBAL INFERTILITY TESTING AND TREATMENT MARKET FORECAST 2019-2027)]についてメールでお問い合わせはこちらでお願いします。


◆H&Iグローバルリサーチのお客様(例)◆